The collaboration will leverage Medi Assist’s proprietary technology to streamline claims processing, enhance transparency, and deliver smarter health benefits to policyholders in the region
VievePharm is renowned for its phytogenic formulations across livestock, equine, and pet care markets
The decision marks a pivotal moment for the Massachusetts-based biotech giant
The construction projects, which have already begun, will be finalised gradually from the end of 2027 through 202
Emcure to distribute Roche's kidney transplant and anemia drugs in India
Zydus has in-licensed FYB206, a proposed biosimilar to immuno-oncology therapy Keytruda (pembrolizumab), exclusively from Formycon AG for the U.S. and Canadian markets
The product addresses a market with approximately $66.8 million in annual sales as of December 2025.
The oral therapy is aimed at adults with chronic spontaneous urticaria (CSU) who do not respond adequately to H1-antihistamines
Asahi Kasei Pharma receives worldwide exclusive rights for the research, development, manufacturing, and marketing of the active ingredients
Subscribe To Our Newsletter & Stay Updated
